Mike Quirk
Technik-/Wissenschafts-/F&E-Leiter bei SAGE THERAPEUTICS, INC.
Profil
Mike Quirk is currently the Chief Scientific Officer at SAGE Therapeutics, Inc. He previously worked as a Director at AstraZeneca Pharmaceuticals LP from 2012 to 2014.
He received his undergraduate and doctorate degrees from the Massachusetts Institute of Technology.
Aktive Positionen von Mike Quirk
| Unternehmen | Position | Beginn |
|---|---|---|
| SAGE THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 09.10.2023 |
Ehemalige bekannte Positionen von Mike Quirk
| Unternehmen | Position | Ende |
|---|---|---|
AstraZeneca Pharmaceuticals LP
 AstraZeneca Pharmaceuticals LP Pharmaceuticals: MajorHealth Technology AstraZeneca Pharmaceuticals LP develops, manufactures and markets prescription pharmaceutical drugs. It sells products related to gastrointestinal, cardiovascular, neuroscience, respiratory and oncology infections. The company was founded in 1953 and is headquartered in Wilmington, DE. | Direktor/Vorstandsmitglied | 01.05.2014 |
Ausbildung von Mike Quirk
| Massachusetts Institute of Technology | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| SAGE THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
AstraZeneca Pharmaceuticals LP
AstraZeneca Pharmaceuticals LP Pharmaceuticals: MajorHealth Technology AstraZeneca Pharmaceuticals LP develops, manufactures and markets prescription pharmaceutical drugs. It sells products related to gastrointestinal, cardiovascular, neuroscience, respiratory and oncology infections. The company was founded in 1953 and is headquartered in Wilmington, DE. | Health Technology |
